| [1] |
中华医学会感染病学分会肝衰竭与人工肝学组;中华医学会肝病学分会重型肝病与人工肝学组.肝衰竭诊治指南(2018年版).实用肝脏病杂志,2019,22(2):164-171.
|
| [2] |
Singal AK,Shan VH.Current trials and novel therapeutic targets for alcoholic hepatitis.J Hepatol,2019,70(2):305-313.
|
| [3] |
Triantafyllou E,Woollard KJ,Mcphail MJW,et al.The role of monocytes and macrophages in acute and acute-on chronic liver failure.Front Immunol,2018,9(12):2948.
|
| [4] |
Chung RT, Stravitz RT, Fontana RJ, et al. Pathogenesis of liver injury in acute liver failure. Gastroenterology, 2012,143: e1-e7.
|
| [5] |
Dong X, Gong Y, Zend H,et al. Imbalance between circulating CD4+ regulatory T and conventional T lymphocytes in patients with HBV-related acute-on-chronic liver failure. Liver Int, 2013, 33:1517-1526.
|
| [6] |
王晓晶, 张小平, 宁琴. 肝衰竭的免疫发病机制. 临床肝胆病杂志,2014, 30: 984-991.
|
| [7] |
Ma TL, Hu TH, Hung CH, et al. Incidence and predictors of retreatment in chronic hepatitis B patients after discontinuation of entecavir or tenofovir treatment. PLoS One, 2019,14(10):e0222221.
|
| [8] |
Puengel T, Tacke F. Repair macrophages in acute liver failure.Gut, 2018,67(2): 202-203.
|
| [9] |
Yan Z,Tan W,Zhao W,et al. Regulatory polymorphisms in the IL-10 gene promoter and HBV-related acute liver failure in the Chinese population.J Viral Hepat,2009,16(11):775-783.[10] Staud F, Ceckpva M, Micuda S, et al. Expression and function of p-glycoprotein in normal tissues: effect on pharmacokinetics.Methods Mol Biol,2010, 596:199-222.
|
| [11] |
Iqbal M, Gibb W, Matthews SG. Corticosteroid regulation of P-glycoprotein in the developing blood-brain barrier. Endocrinology, 2011, 152(3):1067-1079.
|
| [12] |
Foucaud-Vignault M, Soavfane Z, Menez C,et al.P-glycoprotein dysfunction contributes to hepatic steatosis and obesity in mice. PLoS One, 2011, 6(9):e23614.
|
| [13] |
Bernal W,Jalan Quaglia A.Acute-on-chronic liver failure.Lancet,2015,386(10003):1576-1587.
|
| [14] |
Hoofnagle JH.Reactivation of hepatitis B.Hepatology, 2009,49:S156-S165.
|
| [15] |
中华医学会感染病学分会肝衰竭与人工肝学组,中华医学会肝病学分会重型肝病与人工肝学组.肝衰竭诊治指南.中华临床感染杂志,2012,5:321-327.
|
| [16] |
Wong VW,Wong GL,Yiu KK,et al.Entecavir treatment in patient swith severe acute exacerbation of chronic hepatitis B. J Hepatotol,2011,54:236-242.
|
| [17] |
Fujiwara K,Yasui S,Okitsu K,et al.The requirement for a sufficient period of corticosteroid treatment in combination withnucleoside analogue for severe acute exacerbation of chronic hepatitis B.J Gastroenterol,2010,45:1255-1262.
|
| [18] |
Li J,Wu J,Liu HX,et al.Early bilirubin response in acute on chronic hepatitis B liver failure patients treated with corticosteroids predicates a lower 3-month mortality.Int J Clin exp Med,2016,9:10364-10373.
|
| [19] |
Zhang XQ,Liang L,You JP,et al.Efficacy of short term dexamethasone therapy in acute on chronic pre-liver failure.Hepatol Res,2011,41:46-53.
|
| [20] |
Fujiwara K, Nakano M, Yasui S, et al. Advanced histology and impaired liver regeneration are associated with disease severity in acute-onset autoimmune hepatitis. Histopathology, 2011, 58(5):693-704.
|
